meet the expert panel
Sarah Dash, MPH
Alliance for Health Policy
Sarah Dash is the president and chief executive officer at the Alliance for Health Policy. She drives the mission and vision of the Alliance, as well as advances and maintains the reputation of the organization as the leading nonpartisan resource for policymakers and health leaders in an evolving health policy environment. Sarah joined the Alliance in 2014 as the vice president for policy and became president and CEO in May 2017. Sarah has long been an influential force in shaping health policy, having served as a senior aide on Capitol Hill and as a member of the research faculty at the Georgetown University Health Policy Institute’s Center on Health Insurance Reforms. Sarah holds a master’s degree in public health from the Yale School of Public Health and a bachelor’s degree in chemistry and literature from MIT. Sarah also holds an executive certificate in nonprofit management from Georgetown University.
Dr. Mark McClellan, MD, PhD
Duke-Margolis Center for Health Policy
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. With offices in Durham, NC and Washington, DC, the Center is a university-wide Duke initiative that is quickly becoming nationally and internationally-recognized for research, evaluation, implementation, and educational initiatives to improve health policy and health. It integrates Duke’s expertise in the social, clinical, and analytical sciences alongside engagement with health care leaders and stakeholders, to develop and apply policy solutions that improve health, health equity, and the value of health care locally, nationally, and worldwide.
Dr. McClellan is a doctor and an economist whose has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.
At the center of the nation’s efforts to combat the pandemic, Dr. McClellan is the co-author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. His current work on responding to the COVID-19 public health emergency spans virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines.
Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and academic research.
Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.
Dr. McClellan is the founding chair and a Senior Advisor of the Reagan-Udall Foundation for the FDA, serves on the ICER Advisory Board, and is a member of the National Academy of Medicine (NAM). He chairs the NAM’s Leadership Council for Value and Science-Driven Health Care, co-chairs the Guiding Committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He is also a Senior Advisor on the faculty of the University of Texas Dell Medical School and is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.
Dr. Rishi Manchanda, MD, MPH
President & CEO
Dr. Rishi Manchanda is a physician, author, and healthcare leader who has spent more than a decade developing novel strategies to improve health in resource-poor communities. He has served as director of social medicine for a network of community health centers in South-Central Los Angeles, as the lead primary care physician for homeless veterans at the Greater Los Angeles VA, and as chief medical officer for a self-insured employer with a large rural immigrant workforce. In his 2013 TED Book, The Upstream Doctors, and 2014 TED Talk, he introduced readers and viewers to the Upstreamists, a new model of healthcare workers who improve care by addressing patients’ health-related social needs, such as food, financial, and housing insecurity. The talk has been viewed nearly 2 million times, and the book has become recommended reading in medical schools and universities across the world.
Mara Aspinall, MBA
Co-founder & Professor of Practice, Biomedical Diagnostics
Arizona State University
Mara Aspinall co-founded the Biomedical Diagnostics program at Arizona State University’s College of Health Solutions, which is the first program dedicated entirely to diagnostics as an independent discipline. She is Managing Partner of BlueStone Venture Partners and CEO of the Health Catalysts Group, a research and consulting firm for new healthcare companies. Aspinall is the former President and CEO of Ventana Medical Systems / Roche Tissue Diagnostics. Previously, she was President of Genzyme Genetics, the leading genetic testing company. She currently sits on the Board of Abcam, Allscripts, Castle Biosciences, Orasure, and BlueCross BlueShield of Arizona. Aspinall has spearheaded initiatives to educate payers and policymakers on genomics and personalized medicine. She served as an active member of the Health and Human Services Secretary’s Advisory Council on Genetics, Health & Society (SACGHS) in both the Bush and Obama administrations. Aspinall was also a Trustee of the Dana Farber Cancer Institute for 11 years, where she chaired the Trustee Science Committee.
Nancy Guinto, MHA
Washington State Alliance
Nancy Giunto serves as Executive Director of Washington Health Alliance. Since joining the Alliance in September 2014, Nancy has overseen the organization’s strategic direction, including its legislative agenda, continued statewide expansion, and the publication of new reports.
Nancy is also responsible for the Alliance’s partnership with the Washington State Health Care Authority, which includes the development and publication of results for the Washington Common Measure Set on Health Care Quality and Cost.
Previously Nancy served 14 years as executive director of Foster Pepper law firm in Seattle, where she purchased health care for close to 300 attorneys and staff.
Nancy has had a long career in health care, first at National Institutes of Health in Washington D.C. as a program analyst, and then at the American Hospital Association. She spent seven years as an administrative leader at Intermountain Health Care, a large health care system in Salt Lake City. In her last position with Intermountain Health Care, Nancy served as the chief operating officer of the system’s second largest hospital. For ten years she was employed by Providence Health & Services in a variety of positions including chief operating officer and operations administrator for a hospital and special assistant to the CEO working on significant system initiatives.
Nancy is a Board Member of the Network of Regional Healthcare Improvement (NRHI) and serves as chair of the organization’s Strategic Planning Committee as well as on its Executive Committee.
Nancy is very active in the local business community. She was a member of Seattle Rotary 4, one of the largest Rotary clubs in the world, for fifteen years, including serving as the Chairperson of the Rotary Business Mentor Committee. Nancy is also currently a Board member of the Seattle Metropolitan Chamber of Commerce and a member of the Advisory Panel for Cambia Grove.
In 2018, Nancy was invited to testify, on behalf of the Alliance, in the US Senate Health, Education, Labor and Pensions Committee on “Reducing Health Care Costs: Examining How Transparency Can Lower Spending and Empower Patients.”
Nancy graduated summa cum laude from The Ohio State University with a B.S. in biomedical communications. She also earned a Master of Health Administration degree from The Ohio State University.